XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect Adjustment
Convertible Preferred Stock Beginning Balance, Shares at Dec. 31, 2020   30,081,996          
Convertible Preferred Stock Beginning Balance at Dec. 31, 2020   $ 832,625          
Beginning Balance, Shares at Dec. 31, 2020     50,054,880        
Beginning Balance at Dec. 31, 2020 $ (511,107)   $ 50 $ 161,116   $ (672,273)  
Issuance of common stock in connection with amended agreement - related party, Shares     4,080,636        
Issuance of common stock in connection with amended agreement - related party 50,000   $ 4 49,996      
Exercise of stock options and warrants, Shares     181,332        
Exercise of stock options and warrants 540     540      
Stock-based compensation expense 847     847      
Accretion of convertible preferred stock   $ 4,602          
Accretion of convertible preferred stock (4,602)     (4,602)      
Net loss (70,026)         (70,026)  
Convertible Preferred Stock Ending Balance, Shares at Mar. 31, 2021   30,081,996          
Convertible Preferred Stock, Ending Balance at Mar. 31, 2021   $ 837,227          
Ending Balance, Shares at Mar. 31, 2021     54,316,848        
Ending Balance at Mar. 31, 2021 (534,348)   $ 54 207,897   (742,299)  
Convertible Preferred Stock Beginning Balance, Shares at Dec. 31, 2020   30,081,996          
Convertible Preferred Stock Beginning Balance at Dec. 31, 2020   $ 832,625          
Beginning Balance, Shares at Dec. 31, 2020     50,054,880        
Beginning Balance at Dec. 31, 2020 (511,107)   $ 50 161,116   (672,273)  
Accretion of convertible preferred stock 9,404            
Convertible Preferred Stock Ending Balance, Shares at Jun. 30, 2021   30,081,996          
Convertible Preferred Stock, Ending Balance at Jun. 30, 2021   $ 842,029          
Ending Balance, Shares at Jun. 30, 2021     54,603,812        
Ending Balance at Jun. 30, 2021 (559,373)   $ 54 204,871   (764,298)  
Convertible Preferred Stock Beginning Balance, Shares at Mar. 31, 2021   30,081,996          
Convertible Preferred Stock Beginning Balance at Mar. 31, 2021   $ 837,227          
Beginning Balance, Shares at Mar. 31, 2021     54,316,848        
Beginning Balance at Mar. 31, 2021 (534,348)   $ 54 207,897   (742,299)  
Exercise of stock options and warrants, Shares     286,964        
Exercise of stock options and warrants 623     623      
Stock-based compensation expense 1,105     1,105      
Options issued in connection with bonus program 48     48      
Accretion of convertible preferred stock 4,802 $ 4,802          
Accretion of convertible preferred stock (4,802)     (4,802)      
Net loss (21,999)         (21,999)  
Convertible Preferred Stock Ending Balance, Shares at Jun. 30, 2021   30,081,996          
Convertible Preferred Stock, Ending Balance at Jun. 30, 2021   $ 842,029          
Ending Balance, Shares at Jun. 30, 2021     54,603,812        
Ending Balance at Jun. 30, 2021 $ (559,373)   $ 54 204,871   (764,298)  
Beginning Balance, Shares at Dec. 31, 2021 196,804,844   196,804,844        
Beginning Balance at Dec. 31, 2021 $ 723,055   $ 197 1,594,780 $ 629 (871,922) $ (629)
Exercise of stock options, Shares     63,118        
Exercise of stock options 173     173      
Issuance of common stock upon vesting of restricted stock units, shares     758,701        
Issuance of common stock upon vesting of restricted stock units     $ 1 (1)      
Stock-based compensation expense 6,595     6,595      
Stock-based compensation expense for Employee Stock Purchase Plan, or ESPP 196     196      
Net loss (25,147)         (25,147)  
Ending Balance, Shares at Mar. 31, 2022     197,626,663        
Ending Balance at Mar. 31, 2022 $ 704,872   $ 198 1,602,372   (897,698)  
Beginning Balance, Shares at Dec. 31, 2021 196,804,844   196,804,844        
Beginning Balance at Dec. 31, 2021 $ 723,055   $ 197 1,594,780 $ 629 (871,922) $ (629)
Exercise of stock options, Shares 152,322            
Ending Balance, Shares at Jun. 30, 2022 198,077,889   198,077,889        
Ending Balance at Jun. 30, 2022 $ 688,591   $ 198 1,611,828   (923,435)  
Beginning Balance, Shares at Mar. 31, 2022     197,626,663        
Beginning Balance at Mar. 31, 2022 704,872   $ 198 1,602,372   (897,698)  
Exercise of stock options, Shares     89,204        
Exercise of stock options $ 252     252      
Issuance of common stock upon vesting of restricted stock units, net of shares surrendered for taxes, shares     254,908        
Issuance of common stock for settlement of contingent consideration, Shares 20,564   20,564        
Issuance of common stock for settlement of contingent consideration $ 344     344      
Issuance of common stock under ESPP, Shares     86,550        
Issuance of common stock under ESPP 602     602      
Stock-based compensation expense 8,113     8,113      
Stock-based compensation expense for Employee Stock Purchase Plan, or ESPP 145     145      
Net loss $ (25,737)         (25,737)  
Ending Balance, Shares at Jun. 30, 2022 198,077,889   198,077,889        
Ending Balance at Jun. 30, 2022 $ 688,591   $ 198 $ 1,611,828   $ (923,435)